Setting the standard for Inhaled Nicotine Replacement Therapies
Liber aims to prove the safety and efficacy of inhalation-based therapies as methods of administering medicines.
Through its suite of inhaled Nicotine Replacement Therapy (iNRT) products, Liber is focused on vaporiser technology as an intervention for smoking cessation.
Transition to Nicovape® Q2 System Complete
Liber Pharmaceuticals has now discontinued its Nicovape® Q A1 device and associated Nicovape® Q | QSD cartridge SKUs, and completed transitioning all users to the new Nicovape® Q2 system.
The
Liber
difference
01
Locally supplied and fully insured
Liber is the only Nicotine Vaping Product (NVP) manufacturer who has acquired Australian-issued product liability insurance.
02
Characterised and assessed liquids
Characterisation of all flavour compounds, subjected to comprehensive toxicological risk and hazard assessments for inhalation.
03
Domestic pharmacy distribution
Nicovape® Q is the only NVP supplied by pharmaceutical wholesalers (Symbion, Sigma and API) to over 5,500 community pharmacies nationwide.
Find us in your local pharmacy
Over 2,200 community pharmacies nationwide currently hold stock of the Nicovape® Q range in-store.
Interested in stocking Nicovape® Q?
Speak with your national wholesaler SAS representative
-
Transition to Nicovape® Q2 System Complete
Liber Pharmaceuticals has now discontinued its Nicovape® Q A1 device and associated Nicovape® Q | QSD cartridge SKUs, and completed transitioning all users to the new Nicovape® Q2 system.
January 9, 2025 -
Big tobacco and Chemist Warehouse battling to gain market share in Australia’s pharmacy vape market
Big tobacco and Chemist Warehouse battling to gain market share in Australia’s pharmacy vape market December 11, 2024 Posted by: Liber Category: Australian news & media No Comments ABC News has published an in-depth look at the changing landscape of Australia’s pharmacy vaping market, spotlighting Liber Pharmaceuticals’ emergence as a key player in the sector.
December 11, 2024
Find us in your local pharmacy
Over 2,000 community pharmacies nationwide currently hold stock of the Nicovape® Q range in-store.
Interested in stocking Nicovape® Q?
Speak with your national wholesaler SAS rep